DCPrime in the media

DCPrime in the media

May 23, 2016
Immunity against cancer: dedicated to prove it does work for patients

March 21, 2016
Ada Kruisbeek: Mastering Immunity Europe 2016

February 2, 2016
DCPrime CEO Ada M. Kruisbeek interview 

January 28, 2016
DCPrime and VUmc awarded HORIZON 2020 grant

February 20, 2015
Vaccineren tegen kanker 

March 7, 2014
Bedrijf moet verkassen voor zak provinciegeld.

December 9, 2013
Vaccine in de maak tegen acute leukemie.

December 5, 2013
Biedt nieuw kankervaccin toekomst?

November 30, 2013
Johnson & Johnson ‘ontdekt’ kankervaccinbedrijf DCPrime

October 9, 2013
'Johnson&Johnson becoming the first big pharma to make a move into dendritic cell technology..'

October 3, 2013
Cancer Vaccine Company DCPrime and Janssen To Collaborate on Potential New Therapy

July 8, 2013
TI Pharma's launch of the SME Partnership Call has created important new opportunities for DCPrime

May, 2013
DCPrime's Phase I/IIa Trial with Dendritic Cancer Vaccine in Acute Myeloid Leukemia meets all Clinical Endpoints

May, 2012
DCPrime flirt met de grote farmabedrijven

November, 2011
Interview DCPrime founder Ada Kruisbeek and investor Thuja Capital (in Dutch)

October, 2011
Nieuwsbrief Agentschap NL, Overview results DCPrime projects supported by Agentschap (in Dutch)

September, 2011
DCPrime BV: Kansen realiseren dankzij financiële steun

June, 2011
Press release BioLife Solutions, Announcement succesful use CryoStor freezing media for DCPrime's first clinical product

April, 2011
Partnering News, Bringing cell based vaccines to market

March, 2011
Bio Preservation Today, manufacturing of a dendritic cell vaccine platform

Last updated: november 13, 2017